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The intestinal mucus layer and endogenous microbiota are strongly intertwined and this contributes to the maintenance of the epithelial barrier and
ultimately of gut homeostasis. To understand the molecular foundations of such relationship, we investigated if the nature of the microbiota
transcriptionally regulates mucus layer composition in vivo.We found that the expression of mucins 1 to 4 and trefoil factor 3 was down-regulated in the
ileum and colon of conventional and reconventionalized mice compared with germ-free animals. Conversely, very limited colon-restricted changes in
transmembrane mucins were detected in mice colonized with human adult or baby microbiota. Moreover, by microarray analysis, the murine
endogenous microbiota was found to modulate genes putatively involved in mucin secretion. These findings show that a well-established microbial
community participates in the regulation of the gut mucus layer and that its composition and adequacy to the host are key factors in this process.
© 2007 Elsevier Inc. All rights reserved.Keywords: Bacteria; Cytoskeleton; Intestine; Microarray analysis; MucinIt has long been alleged that the developmental program in
the gastrointestinal tract is genetically pre-encoded and that
genes are therefore switched on at predefined time points during
the maturation process. Recently, a new hypothesis has emerged
suggesting that the intestinal microbiota act as an environmental
factor that drives gene expression in the host epithelium by
signaling to genetically predisposed cells [1]. This hypothesis
confers additional significance to the previous discovery that
the endogenous microbiota directly modulate gene expression
in the epithelium, thus affecting several physiological processes
of the intestinal tract [2,3].
The intestinal microbial population comprises millions of
cells from the Archaea, Bacteria, and Eukarya, both in mouse☆ Supplementary data for this article may be found on ScienceDirect.
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doi:10.1016/j.ygeno.2007.09.006and in human [4]. The shaping of this endogenous community
follows a typical postnatal developmental pattern, characterized
by abrupt changes at weaning [5], that parallels the establish-
ment of the mucus layer and the overall gut barrier [6]. It is
straightforward to suppose that mucus and microbiota inter-
twine so as to impact on the maintenance of gut homeostasis and
a global healthy status of the body.
The role of the microbiota in regulating the formation of a
mature mucus layer may be crucial in early life and deserves more
investigation. Pioneering work showed that in germ-free mice, the
pre-epithelial mucus layer is reduced by half, is less stable and
compact [7], and has an altered glycosylation profile compared to
conventional animals [8,9]. Twelvemucin gene transcripts (MUC)
have been detected in the human gastrointestinal tract [10]. MUC
genes are differently expressed by all intestinal epithelium cell
types, MUC1–4 being predominant. In particular, MUC2 is the
main secreted colonic mucin [11]. Mucins are cosecreted with
the trefoil factors [12], amongwhich TFF3 is themost abundant in
the intestine, which contribute to the viscoelastic properties of the
mucus gel [13]. While gram-positive and gram-negative bacteria
have been reported to up-regulate mucin expression in airway
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that intestinalmucin expressionmay be regulated by bacteria came
from studies using probiotics. In vitro, different Lactobacilli
strains have been reported to either up-regulate MUC gene ex-
pression or not have any effect in colonic epithelial cell lines [16–
18]. In vivo, the probiotic mixture VSL#3 was not able to mo-
dulate mucin gene expression nor thickness of the murine colonic
mucus layer [19], while it produced an increase inMUC1, 2, and 3
in rat colonic loops [20]. Also, feeding 1- to 14-day-old chicks
with probiotics or an antibiotic growth promoter enhanced mucin
gene expression and synthesis in their jejunum and ileum [21].
Thus, the effect of nonpathogenic exogenous bacteria on intestinal
mucins is still unclear. Furthermore, the effect of the endogenous
bacteria is unknown.
The aim of the present study was to investigate whether
bacteria residing in the gut can act as an environmental factor
regulating mucus components transcriptionally. To this end, we
evaluated gene expression profiles in conventional and recon-
ventionalized mice and in mice associated with a microbiota
derived from either human baby or human adult intestine and
compared them to those found in germ-free animals. The as-
sociation with foreign but physiologically appropriate micro-
biota will show if the host response is merely related to the
presence of the bacteria or depends on distinct signals elicited
by microbial communities of different natures.
Results
Gene expression of MUC1, 2, 3, and 4 and TFF3 in the intestine
depends on the presence and composition of the gut microbiota
To investigate if the endogenous microbiota of the gut
modulates, in vivo, the transcriptional expression of the major
components of the mucus layer, we studied, by real-time PCR,Fig. 1. Real-time PCR analysis of the expression of Muc1–4 and Tff3 in the ileum an
adult (MAM), human adult (HAM), or human baby (HBM) microbiota. Fold ch
normalization to GAPDH and represent the means of five animals. Values higher tha
indicate higher expression in germ-free mice (⁎significant change, test rejection levthe expression of Muc1, Muc2, Muc3, Muc4, and Tff3 in the
ileum and colon of conventional and germ-free mice. As shown
in Fig. 1, all genes considered were found to be significantly
less expressed in conventional than in germ-free animals. To
tackle the effect of the nature of the intestinal microbiota on the
expression of these genes, we associated germ-free mice with
complex microbiota originating from murine adult, human
adult, or human baby feces. Similar to conventional animals, in
mice reconventionalized with murine microbiota, mucin and
Tff3 gene expression was significantly lower than in germ-
free animals, in both ileum and colon. Moreover, fold changes
were of analogous magnitude in conventional mice and in mice
associated with murine microbiota.
Comparing gene expression in germ-free mice and in mice
associated with human microbiota we observed that, in contrast
to the murine community, neither type of human microbiota
transcriptionally modulated Muc2 and Tff3 (Fig. 1). Further-
more, even though Muc1, Muc3, and Muc4 were modulated by
the human adult microbiota (HAM), the effect was observed
only in colon and the changes were much less important than
those induced by the murine microbiota. Comparing the two
human bacterial communities from a global perspective, human
adult microbiota induced more marked changes on MUC gene
expression than human baby microbiota (HBM); however, ex-
cept forMuc4, these variations were minor if compared to those
elicited in mice reconventionalized with murine microbiota.
The microbiota regulate the expression of cytoskeleton genes
putatively involved in mucus-containing vesicle intracellular
trafficking
To examine if the impact of the commensal microbiota on
mucus layer composition extends beyond MUC gene expres-
sion modulation, we analyzed global gene expression in thed colon of conventional mice (CONV) and of mice associated with fecal murine
ange and statistical significance were calculated versus germ-free mice after
n 1 indicate higher expression in colonized mice, while values between 0 and 1
el: 0.05).
Table 1
Cellular components gene ontology analysis of the probe sets modulated by the presence of the microbiota in ileum and colon at p≤0.001
GO node Description p value Number of probe sets
(total, up, down)
Ileum Colon Ileum Colon
5615 Extracellular space 5.89×10−51 7.63×10−71 45, 14, 31 66, 30, 36
5576 Extracellular 6.89×10−23 2.51×10−23 10, 0, 10 8, 1, 7
5634 Nucleus 3.97×10−5 3.76×10−16 21, 7, 14 66, 25, 41
5768 Endosome 2.60×10−7 2.27×10−10 0 3, 0, 3
5770 Late endosome 1.50×10−9 3.42×10−8 4, 3, 1 3, 1, 2
5856 Cytoskeleton 4.16×10−5 2.29×10−8 2, 1, 1 3, 2, 1
5694 Chromosome 1.52×10−8 2.19×10−4 2, 0, 2 4
786 Nucleosome 8.59×10−7 7.32×10−6 1, 0, 1 4, 3, 1
5862 Muscle thin filament tropomyosin 1.92×10−5 2.62×10−7 1, 0, 1 2, 0, 2
5886 Plasma membrane 7.86×10−6 3.34×10−7 6, 6, 0 6, 3, 3
5771 Multivesicular body 1.48×10−6 7.48×10−4 10, 10, 0 6, 6, 0
785 Chromatin 1.49×10−6 5.57×10−6 1, 0, 1 2, 2, 0
15629 Actin cytoskeleton 6.39×10−6 1.61×10−6 3, 0, 3 6, 1, 5
5578 Extracellular matrix 2.21×10−6 1.64×10−4 3, 1, 2 4, 1, 3
5794 Golgi apparatus NS 2.42×10−6 5, 2, 3
5876 Spindle microtubule 4.46×10−6 NS 1, 0, 1
30027 Lamellipodium 1.22×10−3 3.03×10−6 2, 1, 1 3, 0, 3
42571 Immunoglobulin complex, circulating 4.81×10−6 1.69×10−5 6, 6, 0 5, 5, 0
19814 Immunoglobulin complex 4.81×10−6 1.69×10−5 0 0
5865 Striated muscle thin filament 1.48×10−4 5.57×10−6 0 0
48471 Perinuclear region NS 5.57×10−6 3, 0, 3
5769 Early endosome 9.92×10−6 6.42×10−5 2, 1, 1 2, 1, 1
9986 Cell surface 1.07×10−5 NS 6, 5, 1
119 Mediator complex 1.28×10−5 3.10×10−3 1, 0, 1 1, 0, 1
16324 Apical plasma membrane 1.40×10−5 9.05×10−5 2, 2, 0 2, 0, 2
30017 Sarcomere 6.73×10−5 1.49×10−5 0 0
922 Spindle pole NS 1.72×10−5 1, 0, 1
5829 Cytosol 1.86×10−5 1.03×10−4 6, 3, 3 7, 5, 2
30016 Myofibril 7.71×10−5 1.78×10−5 0 0
5813 Centrosome NS 1.82×10−5 2, 0, 2
5819 Spindle 1.11×10−3 4.31×10−5 0 0
30484 Muscle fiber 1.51×10−3 7.15×10−5 0 1, 1, 0
9897 External side of plasma membrane 8.50×10−5 NS 8, 8, 0
5815 Microtubule organizing center NS 2.68×10−4 0
5581 Collagen 3.38×10−4 NS 2, 0, 2
19815 B cell receptor complex 4.44×10−4 8.33×10−4 6, 6, 0 5, 5, 0
1772 Immunological synapse 4.72×10−4 NS 0
12506 Vesicle membrane 4.04×10−3 7.72×10−4 1, 0, 1 1, 0, 1
5942 Phosphoinositide 3-kinase complex 1.44×10−3 4.91×10−3 1, 0, 1 1, 0, 1
5730 Nucleolus 1.69×10−3 NS 2, 0, 2
12505 Endomembrane system NS 1.86×10−3 0
5884 Actin filament 1.88×10−3 NS 2, 0, 2
5764 Lysosome NS 1.99×10−3 4, 3, 1
15630 Microtubule cytoskeleton NS 2.28×10−3 2, 2, 0
5657 Replication fork 2.32×10−3 NS 1, 0, 1
5654 Nucleoplasm NS 2.50×10−3 0
16604 Nuclear body NS 2.73×10−3 1, 0, 1
5777 Peroxisome NS 2.79×10−3 3, 1, 2
5789 Endoplasmic reticulum membrane NS 2.87×10−3 2, 2, 0
16591 DNA-directed RNA polymerase II, holoenzyme 3.13×10−3 NS 0
42175 Nuclear envelope–endoplasmic reticulum network NS 3.14×10−3 0
5956 Protein kinase CK2 complex NS 3.22×10−3 1, 1, 0
1750 Photoreceptor outer segment NS 3.33×10−3 1, 1, 0
42579 Microbody NS 3.43×10−3 0
16323 Basolateral plasma membrane NS 3.75×10−3 1, 1, 0
45095 Keratin filament NS 3.82×10−3 1, 1, 0
323 Lytic vacuole NS 4.01×10−3 0
30891 VCB complex NS 6.65×10−3 1, 0, 1
776 Kinetochore NS 6.92×10−3 2, 0, 2
42589 Zymogen granule membrane NS 7.48×10−3 1, 1, 0
9925 Basal plasma membrane NS 7.48×10−3 1, 1, 0
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GO node Description p value Number of probe sets
(total, up, down)
Ileum Colon Ileum Colon
5773 Vacuole NS 8.22×10−3 0
42613 MHC class II protein complex 8.84×10−3 NS 1, 1, 0
42611 MHC protein complex 8.84×10−3 NS 0
30667 Secretory granule membrane NS 9.96×10−3 0
42588 Zymogen granule NS 9.96×10−3 0
5912 Adherens junction NS 9.98×10−3 0 1, 0, 1
Only nodes associated with a p≤0.01 are listed (GO, Gene Ontology; NS, not significant). In the last two columns, up and down indicate how many probe sets, among
the total contained in each node, had a higher or lower expression in conventional mice, respectively; annotation of each probe set and corresponding fold are given in
Supplementary Table S1. “0” indicates that probe sets annotated to the node could be further associated with its children (more specific) and therefore they do not
appear in the parent node; they can be found in Supplementary Table S2.
Table 1 (continued)
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microarray technology. Twelve chips were used (6 per group).
The presence of the microbiota significantly affected 739 and
1600 probe sets in ileum and colon, respectively (p≤0.001). A
complete list of these probe sets, together with their annotation
and associated signal intensities, is given in Supplementary
Table S1. While Muc2 and Muc4 are not included in the
MGU74Av2 array, probe sets representing Muc1, Muc3, and
Tff3 do not appear in this list, since they were not selected by
the statistical analysis as being differentially expressed. This
may be due to intrinsic limits of the Robust Multiarray Analysis
algorithm when applied to probe sets associated with low ex-
pression or small fold change [22,23].
We analyzed modulated genes using the biological processes,
molecular function, and cellular components gene ontologies, as
described under Materials and methods. The entire set of data is
presented in Supplementary Table S2. In the three ontologies,
both nodes commonly or specifically modulated in ileum and/or
colon could be identified. Among the biological processes, the
glucocorticoid receptor signaling pathway (Gene Ontology
(GO) ID 42921) and regulation of transport (GO ID 51049)
were those associated with the lowest p value in ileum and
colon, respectively, but a number of processes were commonly
regulated in both regions, including intracellular signaling
cascade (GO ID 7242), B cell activation (GO ID 42113), and
chromatin assembly or disassembly (GO ID 6333). Clustering
with the molecular function ontology revealed protein binding
(GO ID 5515) as the node with the most significant regulation, in
both ileum and colon. Several functions were specifically
modulated in each tissue, including ligand-dependent nuclear
receptor transcription coactivator activity (GO ID 30374) and
RNA polymerase II transcription mediator activity (GO ID
16455) in the ileum and zinc ion binding (GO ID 8270) and
chromatin binding (GO ID 3682) in the colon, while others such
as cytoskeletal protein binding (GO ID 8092) were modulated in
both regions. Finally, according to the cellular component
ontology analysis the extracellular space node (GO ID) was
found to be the most modulated in ileum and colon. Most of the
other nodes, such as endosome (GO ID 5768), nucleus (GO ID
5634), cytoskeleton (GO ID 5856), and chromosome (GO ID
5694), among the top ones, were significantly modulated in both
regions (Table 1).Even though a node was found to be commonly modulated
in ileum and colon, the number of genes mapping to the node
could be different between the two regions. Moreover, there
might be a different number of up- and down-regulated probe
sets associated with it. This is exemplified in Table 1 for the
cellular component ontology analysis and may indicate a
region-specific effect of the gut microbiota.
As noted above, the cytoskeleton node was among those
commonly modulated in ileum and colon. Cytoskeleton com-
ponents, namely microtubules and actin filaments, have been
previously described to be involved in the secretion of mucin
granules in the intestine [24,25]. Therefore, we hypothesized that
mucin trafficking and secretion might be affected by the
microbiota. To extrapolate relevant data, we constructed a gene
set containing genes coding for proteins known to be part of or to
be involved in the synthesis of the cytoskeleton, or to interact with
any of its components, and we examined their modulation in our
Affymetrix dataset. Six and sixteen percent of the probe sets
contained in this gene set were significantly modulated by the
microbiota in the ileum and colon, respectively. Moreover, in the
two intestinal regions, most of the genes being regulated were less
expressed in conventional than in germ-free animals (Fig. 2). By
clustering the differentially expressed genes using gene ontolo-
gies, the cytoskeleton organization and biogenesis node were
found to be significantly modulated in both tissues (p≤0.001).
The expression of genes coding for the three main components
of the eukaryote cytoskeleton, namely microfilaments (actin),
intermediate filaments (keratin), and microtubules (tubulin),
were affected by themicrobiota (Fig. 2). In particular, cytoplasmic
β-actin was more highly expressed in germ-free mice. An
increased synthesis of actin has been correlatedwith less secretion
of mucin granules from airway goblet cells [26]. Our data point to
the fact that this may be true in the intestine as well.
Furthermore, we considered the possible involvement of the
microbiota in modulating mucin glycosylation pattern. Indeed,
while mucin glycan chains may mediate attachment as well as
serving as a carbon source for commensal bacteria [27], it is
still unclear to what extent the microbial community affects their
synthesis. Mucin glycan synthesis starts with the addition of
N-acetylgalactosamine to serine or threonine residues of the apo-
mucin. The glycan is then sequentially elongated by the addition
of galactose and/or N-acetylglucosamine moieties, frequently
Fig. 2. Genes contained in the Cytoskeleton gene set and associated with a fold change higher than 1.5 (p≤0.001) and with an expression level of at least 150 in at least
one intestinal region. Gene titles correspond to the Affymetrix annotation, unless indicated in parentheses. Biological process descriptions were obtained by clustering
differentially expressed genes using Gene Ontology and correspond to the deepest significant nodes (pb0.001). Fold change represents the ratio of expression in
conventional versus germ-free mice (I, ileum; C, colon).
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fucose [28]. We constructed a gene set containing probe sets
representing glycosyltransferases and nucleotide sugar transpor-
ters. Since not all of these genes have been assigned to GO nodes
yet, we used the glycogene list compiled from the Consortium for
Functional Glycomics (www.functionalglycomics.org) for cate-
gory assignments. The expression of most of the glycogenes was
not affected by the presence of the microbiota. Nevertheless, in
this case aswell, the number of probe sets significantly modulated
in colon exceeded the number of those modulated in ileum.
Moreover, except for ST6GalNAc4 (96682_at) and ppGalNAcT4
(101333_at), whose regulation (up and down, respectively) is
borderline in the colon of conventional animals, among the gly-
cogenes represented on the MG-U75Av2 chip, those modulated
by themicrobiota are mostly involved in the synthesis of N-linked
glycans (94432_at, 101074_at, 95417_at, 99423_at), glycolipids
(102936_at, 100369_at, 98872_at, 94197_a), and prote-
oglycans (102811_at, 102410_at) and not in mucin glycosylation
(O-glycans) (Supplementary Table S1).
Discussion
The involvement of the endogenous microbiota in the
regulation of the intestinal epithelial barrier function is pre-dictable but the molecular mechanisms remain largely unknown.
In the present study, we show that the intestinal microbiota
transcriptionally regulates the mucus layer and that its bacterial
composition influences this process. First, we compared con-
ventional and germ-free mice to establish the involvement of gut
microbiota on mucin expression. We observed that, while all of
the MUC genes considered are expressed in both conventional
and germ-free animals, they all are down-regulated in the first.
This result is consistent with previous findings documenting
increased mucin protein synthesis in germ-free mice [29], despite
the reduced number of goblet cells in their intestinal epithelium
[30,31]. These data, combined with the observation of higher
trefoil factor 3 expression in germ-free animals, suggest that these
mice may up-regulate mucin synthesis as a defense mechanism,
so as to compensate for the lack of endogenous microbiota acting
as a first defense against luminal aggression.
To investigate further the impact of the bacterial ecosystem
as an environmental factor affecting mucin gene expression, we
used mice associated with microbiota of different compositions
and origins. Gene modulation in animals associated with murine
adult microbiota was analogous to that observed in conven-
tional mice, showing that the reconventionalization procedure
does not impact on the measured outcome. In contrast to murine
adult microbiota, human microbiota did not dramatically affect
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induced some changes in MUC expression in the colon, the
magnitude of these changes was low compared to those induced
by the murine microbiota. In addition, human baby microbiota
had even less impact than that of the human adult, suggesting
that some bacterial groups, absent from the baby microbiota, are
likely required to produce adequate signals. These findings
show that the cross talk between bacteria coming from a human
ecosystem and the mouse intestine is not as efficient as in
conventional or reconventionalized mice and highlight that the
adequacy between the host and its own bacterial profile is likely
to play a key role in modulating mucus composition. This
hypothesis is further supported by the fact that MUC4, a mem-
brane mucin implicated in cellular signaling [32], is affected by
the human and murine microbiota in opposite manners.
Moreover, previous studies of germ-free mice associated with
a human adult microbiota showed that, in these animals, the
development of the small intestinal immune system is impaired
compared to in conventional mice, due to the lack of colonization
by segmented filamentous bacteria [33,34]. In the present study,
we observed a good establishment of Enterobacteriaceae, Bac-
teroides, and Bifidobacteria in the murine gut, independent of the
age of the human donor (Supplementary Table S3). In contrast,
human Enterococci and Lactobacilli did not colonize the intestine
of HAM mice and were absent in the gavage administered to
HBMmice. This suggests that these groups of bacteriamay play a
role in the regulation of mucin expression in the intestinal tract.
Previously published studies show that, in vitro, probiotic Lac-
tobacilli strains such as Lactobacillus rhamnosus GG and Lac-
tobacillus Lp299v can up-regulate colonic expression of MUC2
and MUC3 [16,35], as well as, in vivo, the probiotic mixture
VSL#3, which contains Streptococcus, Lactobacillus, and Bifi-
dobacterium species [20]. On the other hand, Lactobacillus
salivarius UCC118 and Lactobacillus acidophilus DDS did not
increase MUC3 expression in the HT-29 colonic epithelium cell
line [16,18]. Therefore MUC gene expression regulation by
Lactobacilli seems to be strain-specific. Our results suggest that a
complex bacterial community containing Lactobacilli would
down-regulate MUC gene expression, in both ileum and colon.
However, neither previous results nor ours permit a conclusion on
the involvement of the gut-resident Lactobacilli in mucin
expression regulation, and more thorough experiments would
be needed to investigate this matter further.
In any case, since the response of the intestinal epithelium to
microbial colonization depends on the origin of the bacteria, as
discussed above, to investigate further the molecular founda-
tions of the gut endogenous bacteria–mucus relationship in a
physiologically relevant systemwe used conventional and germ-
free animals.
To find out if there are mucus-related processes transcrip-
tionally affected by the microbiota other than MUC gene
expression, we ran a whole-genome gene expression analysis
and found that several cytoskeleton genes are significantly less
expressed in the ileum and colon of conventional animals com-
pared to germ-free. Cytoskeletal genes have also been reported
to be modulated by the gut resident bacterium Bacteroides
thetaiotaomicron in the murine ileum [2]. Modulated genesinclude members from the three constituents of the cytoskeleton,
namely actin microfilaments, microtubules, and keratin inter-
mediate filaments. These, and in particular actin, have been
described to be involved in mucus granule secretion [24–26].
Therefore, these findings suggest an involvement of the
microbiota in mucus granules trafficking. Microdissection of
goblet cells and enterocytes and analysis of the cell-type-specific
mRNA profiles would confirm this hypothesis.
Finally we evaluated the impact of the microbiota on gly-
cogene expression. Mainly enzymes involved in the synthesis of
N-glycans, and not O-glycans, appeared to be transcriptionally
modulated, thus excluding an impact of the microbiota on
mucin glycan chain extension.
In summary, this study suggests that the impact of the gut
microbial community on the composition of the mucus layer
spans different levels at the transcriptional stage. These com-
prise MUC gene expression regulation and possibly mucin
secretion. Moreover, gut microbiota composition and its ade-
quacy to the host are important factors in this process. Hence,
interventions leading to modifications of the gut microbiota
could be a strategy to modulate mucus composition in the
intestinal tract and therefore to treat intestinal pathologies that
affect the mucus barrier, such as mucositis associated with
cancer chemo- and radiotherapy.
Materials and methods
Animals and diet
Germ-free and conventionally raised male C3H mice, 6 weeks of age, were
obtained from the Nestlé Research Center Animal House (day 1). The germ-free
animals were distributed into three groups (n=5) to be immediately associated, by
intragastric gavage, with either human baby or human adult fecal microbiota
suspended in PBS (0.2 ml per animal). For the protection of extremely oxygen-
sensitive bacteria, the gavage suspensions were prepared in an anaerobic glove box
using prereduced medium and the samples were then protected from oxygen until
gavage. The same gavage was repeated on day 2. Animals belonging to the third
group remained germ-free and were given a PBS gavage. Absence of bacterial
colonization in these animals was verified throughout the entire study by
microscopy examination of feces and by culturing fecal samples on nonselective
medium in aerobiosis and anaerobiosis. Alternatively, germ-free mice were
associated with murine adult fecal microbiota, following the same protocol. The
animals were maintained in sterile plastic isolators, except for the conventional
group (n=5), and were fed on a standard UAR 03-40 diet (SAFE, Villemoisson/
Orge, France), sterilized by γ-irradiation, and sterile water ad libitum. The animals
were sacrificed on day 22 by exhaustive bleeding under isoflurane anesthesia. The
whole intestine was immediately removed and the contents of the small intestine
and colon were collected for microbiota composition analysis. The tissues
corresponding to the ileum and colon were dissected, snap-frozen, and stored at
−80 °C for RNA preparation. The study design and procedures were approved by
the Service Vétérinaire Cantonal ethical committee (Lausanne, Switzerland).
Gavages and gut microbiota composition analysis
The fecal murine microbiota gavage was prepared by 100-fold dilution in
PBS of 2 g of freshly passed feces collected from adult males. The fecal human
microbiota gavage was obtained by 100-fold dilution in PBS of 5 g of freshly
passed feces collected from an adult male. The human baby microbiota gavage
consisted of a consortium of seven species, previously isolated from the feces of a
20-day-old baby delivered naturally and breast-fed, comprising Bifidobacterium
breve NCC452, Bifidobacterium longum NCC572, Staphylococcus aureus
FSM124, Staphylococcus epidermidis FSM115, Escherichia coli FSM325,
Bacteroides distasonis FSM24, and Clostridium perfringens FSM C14.
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collected at sacrifice from small intestine and colon were immediately analyzed
for the endogenous populations on selective or semiselective media, as pre-
viously described [36]. Total aerobes and anaerobes were quantified on
trypticase soy agar supplemented with 5% sheep blood (bioMerieux, Marcy
L'Etoile, France) and S. aureus on Chapman medium (bioMerieux). The bac-
terial load of the gavage solutions, of the intestinal contents, and of feces is given
in Supplementary Table S3.
RNA preparation
Total RNA was extracted from whole-thickness ileum and colon using the
Tripure Isolation reagent (Roche Diagnostics AG, Rotkreuz, Switzerland)
following the manufacturer's protocol and further purified with the Nucleospin
kit (Macherey-Nagel AG, Oensingen, Switzerland), which includes an on-
column DNase I treatment step. The recovered RNA was quantified using the
RiboGreen RNA Quantification kit (Molecular Probes, Basel, Switzerland) and
its quality was assessed with an Agilent 2100 Bioanalyzer and the RNA 6000
Nano LabChip kit (Agilent Biotechnologies, Waldbronn, Germany).
Real-time RT-PCR analysis of mucins and Tff3 gene expression
TaqMan real-time PCR was carried out in a ABI 5700 thermocycler
(Applied Biosystems, Rotkreuz, Switzerland) using RNA reverse-transcribed
with the Reverse Transcription System (Catalys AG, Zurich, Switzerland) and
oligo(dT) as a primer. Primers and TaqMan probes were purchased from Applied
Biosystems; those for Muc1, Muc2, Muc4, and Tff3 were available on demand,
while those for Muc3 were obtained through the By Design service and were as
follows: forward primer, 5′-TGGTCAACTGCGAGAATGGA-3′; reverse
primer, 5′-GAGGCTGGTGCACTGACATTT-3′; TaqMan probe, 5′-6-carbox-
yfluorescein–ACGTGGGACGGGCT-3′. Before use, this primer set was
validated and its linearity range of application determined. The reactions were
carried out in triplicate. Data were analyzed using the GeneAmp 5700 SDS
software (Applied Biosystems). Relative gene expression was calculated after
normalization to GAPDH, whose expression had been shown not to vary across
samples by preliminary experiments. Statistical significance of differential
expression versus germ-free mice was determined a posteriori after an ANOVA
(analysis of variance) using a General Linear model procedure. Factors were
treatment, animal nested in treatment, and gene; interactions were treatment×
gene and animal×gene. The mean-square interaction animal×gene term was
used to calculate the significance of the changes versus germ-free mice.
Microarray hybridization
Five micrograms of total RNA obtained from whole-thickness ileum and
colon of three mice per group (conventional and germ-free) was independently
reverse transcribed, amplified, and biotin labeled using the SuperScript Choice
System (Invitrogen AG, Basel, Switzerland) and the Bioarray High Yield RNA
Transcription Labeling Kit (Enzo Life Sciences, Farmingdale, NY, USA). The
obtained cRNAs were hybridized to the Murine Genome Array U74Av2
(Affymetrix, High Wycombe, UK) according to the manufacturer's protocols.
The chips were scanned at 488 nm with an argon-ion laser (Agilent
Biotechnologies, Rotkreuz, Germany) and expression signals were generated
using the Robust Multiarray Analysis algorithm [37]. The whole dataset has
been deposited at the Gene Expression Omnibus repository (http://www.ncbi.
nlm.nih.gov/geo/) under Accession No. GSE3304.
Microarray data analysis
Statistical significance of differential gene expression between germ-free and
conventional mice was evaluated by two-factors ANOVA followed by a posteriori
treatment comparison in each of the two intestinal regions, using the Global Error
Assessment model [38] at a test rejection level of 0.001. Genes significantly
affected by the presence of the microbiota were then functionally clustered using
GO (http://www.geneontology.org/) and an in-house-implemented procedure
based on determining the proportion of genes mapping to each GO node, as
previously described [3]. This allowed not only the functional annotation of theselected genes according to the GO database, but also the identification of
significantly modulated biological processes and cellular components (pb0.001).
In addition, to mine for relevant data, we constructed two gene sets named
Cytoskeleton and Glycogenes, containing 511 and 125 probe sets, respectively,
using as information sources the literature and gene ontologies. Since not all of the
glycogenes have been assigned to GO nodes yet, for this gene set we used the
glycogene list compiled by the Consortium for Functional Glycomics (www.
functionalglycomics.org). The list of probe sets included in each gene set is
provided in Supplementary Table S4.A fold of 1.4 has been suggested as the lowest
that can be accurately detected [39] and has indeed been used in studies employing
the same chip as the current research [40]. Therefore, to identify biological
processes significantly modulated by the endogenous microbiota within the gene
sets, genes associatedwith an expression signal of at least 150 and a significant fold
change between conventional and germ-freemice of at least 1.5were selected to be
clustered using the Biological Process Gene Ontology.Acknowledgments
We thank Massimo Marchesini for skilled supervision of the
animal studies, Catherine Schwartz for animal handling, Gloria
Reuteler for microbiological analyses, Muriel Fiaux for contri-
bution to the microarray analysis, and James Holzwarth and
Andreas Fuerholz for support with the bioinformatics tools. We
also thank Anne Donnet-Hughes and Clara Garcia-Rodenas for
stimulating scientific discussion.
Appendix A. Supplementary data
Supplementary data associated with this article can be found,
in the online version, at doi:10.1016/j.ygeno.2007.09.006.
References
[1] L.V. Hooper, Bacterial contributions to mammalian gut development,
Trends Microbiol. 12 (2004) 129–134.
[2] L.V. Hooper, M.H. Wong, A. Thelin, L. Hansson, P.G. Falk, J.I. Gordon,
Molecular analysis of commensal host–microbial relationships in the
intestine, Science 291 (2001) 881–884.
[3] D.M.Mutch, R. Simmering, D. Donnicola, G. Fotopoulos, J.A. Holzwarth,
G. Williamson, I. Corthesy-Theulaz, Impact of commensal microbiota on
murine gastrointestinal tract gene ontologies, Physiol. Genomics 19 (2004)
22–31.
[4] F. Backhed, R.E. Ley, J.L. Sonnenburg, D.A. Peterson, J.I. Gordon, Host–
bacterialmutualism in the human intestine, Science 307 (2005) 1915–1920.
[5] R.I.Mackie,A. Sghir, H.R.Gaskins,Developmentalmicrobial ecology of the
neonatal gastrointestinal tract, Am. J. Clin. Nutr. 69 (1999) 1035S–1045S.
[6] G. Boudry, V. Peron, I. Huerou-Luron, J.P. Lalles, B. Seve, Weaning induces
both transient and long-lasting modifications of absorptive, secretory, and
barrier properties of piglet intestine, J. Nutr. 134 (2004) 2256–2262.
[7] L. Szentkuti, H. Riedesel, M.L. Enss, K. Gaertner, W. Von Engelhardt, Pre-
epithelial mucus layer in the colon of conventional and germ-free rats,
Histochem. J. 22 (1990) 491–497.
[8] B. Deplancke, H.R. Gaskins, Microbial modulation of innate defense:
goblet cells and the intestinal mucus layer, Am. J. Clin. Nutr. 73 (2001)
1131S–1141S.
[9] R. Sharma, U. Schumacher, V. Ronaasen,M. Coates, Rat intestinal mucosal
responses to a microbial flora and different diets, Gut 36 (1995) 209–214.
[10] A.P. Corfield, N. Myerscough, R. Longman, P. Sylvester, S. Arul, M. Pig-
natelli, Mucins and mucosal protection in the gastrointestinal tract: new
prospects formucins in the pathology of gastrointestinal disease,Gut 47 (2000)
589–594.
[11] K.M. Tytgat, H.A. Buller, F.J. Opdam, Y.S. Kim, A.W. Einerhand, J.
Dekker, Biosynthesis of human colonic mucin: Muc2 is the prominent
secretory mucin, Gastroenterology 107 (1994) 1352–1363.
77E.M. Comelli et al. / Genomics 91 (2008) 70–77[12] L. Thim, Trefoil peptides: from structure to function, Cell. Mol. Life Sci.
53 (1997) 888–903.
[13] L. Thim, F. Madsen, S.S. Poulsen, Effect of trefoil factors on the viscoelastic
properties of mucus gels, Eur. J. Clin. Investig. 32 (2002) 519–527.
[14] A. Dohrman, S. Miyata, M. Gallup, J.D. Li, C. Chapelin, A. Coste, E.
Escudier, J. Nadel, C. Basbaum, Mucin gene (MUC 2 and MUC 5AC)
upregulation by gram-positive and gram-negative bacteria, Biochim.
Biophys. Acta 1406 (1998) 251–259.
[15] J.D. Li, A.F. Dohrman, M. Gallup, S. Miyata, J.R. Gum, Y.S. Kim, J.A.
Nadel, A. Prince, C.B. Basbaum, Transcriptional activation of mucin by
Pseudomonas aeruginosa lipopolysaccharide in the pathogenesis of cystic
fibrosis lung disease, Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 967–972.
[16] D.R. Mack, S. Ahrne, L. Hyde, S. Wei, M.A. Hollingsworth, Extracellular
MUC3 mucin secretion follows adherence of Lactobacillus strains to
intestinal epithelial cells in vitro, Gut 52 (2003) 827–833.
[17] J.M. Otte, D.K. Podolsky, Functional modulation of enterocytes by gram-
positive and gram-negative microorganisms, Am. J. Physiol. Gasterointest.
Liver Physiol. 286 (2004) G613–G626.
[18] A.M. O'Hara, P. O'Regan, A. Fanning, C. O'Mahony, J. Macsharry, A.
Lyons, J. Bienenstock, L. O'Mahony, F. Shanahan, Functional modulation
of human intestinal epithelial cell responses by Bifidobacterium infantis
and Lactobacillus salivarius, Immunology 118 (2006) 202–215.
[19] E. Gaudier, C. Michel, J.P. Segain, C. Cherbut, C. Hoebler, The VSL#3
probiotic mixture modifies microflora but does not heal chronic dextran–
sodium sulfate-induced colitis or reinforce the mucus barrier in mice,
J. Nutr. 135 (2005) 2753–2761.
[20] C. Caballero-Franco, K. Keller, C. De Simone, K. Chadee, The VSL#3
probiotic formula induces mucin gene expression and secretion in colonic
epithelial cells, Am. J. Physiol. Gasterointest. Liver Physiol. 292 (2007)
G315–G322.
[21] A. Smirnov, R. Perez, E. Amit-Romach, D. Sklan, Z. Uni, Mucin dynamics
and microbial populations in chicken small intestine are changed by
dietary probiotic and antibiotic growth promoter supplementation, J. Nutr.
135 (2005) 187–192.
[22] A. Ploner, L.D. Miller, P. Hall, J. Bergh, Y. Pawitan, Correlation test to
assess low-level processing of high-density oligonucleotide microarray
data, BMC Bioinformatics 6 (2005) 80.
[23] R.A. Irizarry, B.M. Bolstad, F. Collin, L.M. Cope, B. Hobbs, T.P. Speed,
Summaries of Affymetrix GeneChip probe level data, Nucleic Acids Res.
31 (2003) E15.
[24] M.G. Oliver, R.D. Specian, Cytoskeleton of intestinal goblet cells: role
of actin filaments in baseline secretion, Am. J. Physiol. 259 (1990)
G991–G997.
[25] M.G. Oliver, R.D. Specian, Cytoskeleton of intestinal goblet cells: role of
microtubules in baseline secretion, Am. J. Physiol. 260 (1991) G850–G857.
[26] C. Ehre, A.H. Rossi, L.H. Abdullah, K. De Pestel, S. Hill, J.C. Olsen, C.W.
Davis, Barrier role of actin filaments in regulated mucin secretion from
airway goblet cells, Am. J. Physiol., Cell Physiol. 288 (2005) C46–C56.[27] J.L. Sonnenburg, L.T. Angenent, J.I. Gordon, Getting a grip on things: how
do communities of bacterial symbionts become established in our
intestine? Nat. Immunol. 5 (2004) 569–573.
[28] J.D. Marth, O-Glycans, Essentials of Glycobiology, Cold Spring Harbor
Laboratory Press, Cold Spring Harbor, NY, 1999, pp. 101–113.
[29] Y. Umesaki, K. Tohyama, M. Mutai, Glycoprotein synthesis in the small
intestine of germfree and conventionalized mice, in: S. Sakaski, A. Ozawa,
K. Hashimoto (Eds.), Recent Advances in Germfree Research, Tokai Univ.
Press, Tokyo, 1981, pp. 273–277.
[30] H. Kandori, K. Hirayama, M. Takeda, K. Doi, Histochemical, lectin–
histochemical and morphometrical characteristics of intestinal goblet cells
of germfree and conventional mice, Exp. Anim. 45 (1996) 155–160.
[31] J.S. McCullogh, B. Ratcliffe, N. Mandir, K.E. Carr, R.A. Goodlad, Dietary
fibre and intestinal microflora: effects on intestinal morphometry and crypt
branching, Gut 42 (1998) 799–806.
[32] K.L. Carraway, V.P. Ramsauer, B. Haq, C.A. Carothers Carraway, Cell
signaling through membrane mucins, BioEssays 25 (2003) 66–71.
[33] Y. Umesaki, Y. Okada, S. Matsumoto, A. Imaoka, H. Setoyama,
Segmented filamentous bacteria are indigenous intestinal bacteria that
activate intraepithelial lymphocytes and induce MHC class II molecules
and fucosyl asialo GM1 glycolipids on the small intestinal epithelial cells
in the ex-germ-free mouse, Microbiol. Immunol. 39 (1995) 555–562.
[34] Y. Okada, H. Setoyama, S. Matsumoto, A. Imaoka, M. Nanno, M.
Kawaguchi, Y. Umesaki, Effects of fecal microorganisms and their
chloroform-resistant variants derived from mice, rats, and humans on
immunological and physiological characteristics of the intestines of ex-
germfree mice, Infect. Immun. 62 (1994) 5442–5446.
[35] D.R. Mack, S. Michail, S. Wei, L. McDougall, M.A. Hollingsworth,
Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing
intestinal mucin gene expression, Am. J. Physiol. 276 (1999) G941–G950.
[36] Y. Guigoz, F. Rochat, G. Perruisseau-Carrier, I. Rochat, E.J. Schiffrin,
Effects of oligosaccharide on the faecal flora and non-specific immune
system in elderly people, Nutr. Res. 22 (2002) 13–25.
[37] R.A. Irizarry, B. Hobbs, F. Collin, Y.D. Beazer-Barclay, K.J. Antonellis, U.
Scherf, T.P. Speed, Exploration, normalization, and summaries of high
density oligonucleotide array probe level data, Biostatistics 4 (2003)
249–264.
[38] R. Mansourian, D.M. Mutch, N. Antille, J. Aubert, P. Fogel, J.M. Le Goff,
J. Moulin, A. Petrov, A. Rytz, J.J. Voegel, M.A. Roberts, The Global Error
Assessment (GEA) model for the selection of differentially expressed
genes in microarray data, Bioinformatics 20 (2004) 2726–2737.
[39] H. Yue, P.S. Eastman, B.B. Wang, J. Minor, M.H. Doctolero, R.L. Nuttall,
R. Stack, J.W. Becker, J.R. Montgomery, M. Vainer, R. Johnston, An
evaluation of the performance of cDNA microarrays for detecting changes
in global mRNA expression, Nucleic Acids Res. 29 (2001) E41.
[40] H.H. Ng, C.E. Frantz, L. Rausch, D.C. Fairchild, J. Shimon, E. Riccio, S.
Smith, J.C. Mirsalis, Gene expression profiling of mouse host response to
Listeria monocytogenes infection, Genomics 86 (2005) 657–667.
